These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 227299)

  • 41. Efficacy and Safety of Low-Dose Versus Standard-Dose Valganciclovir for Prevention of Cytomegalovirus Disease in Intermediate-Risk Kidney Transplant Recipients.
    Halim MA; Al-Otaibi T; Gheith O; Adel H; Mosaad A; Hasaneen AA; Zakaria Z; Makkeya Y; Said T; Nair P
    Exp Clin Transplant; 2016 Oct; 14(5):526-534. PubMed ID: 27310254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention of cytomegalovirus disease in renal allograft recipients.
    Balfour HH
    Scand J Infect Dis Suppl; 1991; 80():88-93. PubMed ID: 1725064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of cytomegalovirus infections in renal transplants].
    Rondeau E; Peraldi MN; Kanfer A; Sraer JD
    Nephrologie; 1991; 12(4):189-92. PubMed ID: 1660570
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA vaccines against cytomegalovirus: current progress.
    Temperton NJ
    Int J Antimicrob Agents; 2002 Mar; 19(3):169-72. PubMed ID: 11932137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Virus-specific cytotoxic lymphocyte responses are predictive of the outcome of cytomegalovirus infection of renal transplant recipients.
    Rook AH; Smith WJ; Burdick JF; Manischewitz JF; Frederick W; Siegel JP; Williams GM; Quinnan GV
    Transplant Proc; 1984 Dec; 16(6):1466-9. PubMed ID: 6095498
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age.
    Adler SP; Starr SE; Plotkin SA; Hempfling SH; Buis J; Manning ML; Best AM
    J Infect Dis; 1995 Jan; 171(1):26-32. PubMed ID: 7798679
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients.
    Snydman DR; Werner BG; Heinze-Lacey B; Berardi VP; Tilney NL; Kirkman RL; Milford EL; Cho SI; Bush HL; Levey AS
    N Engl J Med; 1987 Oct; 317(17):1049-54. PubMed ID: 2821397
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
    Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
    BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccination with a Live Attenuated Cytomegalovirus Devoid of a Protein Kinase R Inhibitory Gene Results in Reduced Maternal Viremia and Improved Pregnancy Outcome in a Guinea Pig Congenital Infection Model.
    Schleiss MR; Bierle CJ; Swanson EC; McVoy MA; Wang JB; Al-Mahdi Z; Geballe AP
    J Virol; 2015 Oct; 89(19):9727-38. PubMed ID: 26178990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Absence of association between cytomegalovirus infection and obliterative transplant arteriopathy in renal allograft rejection.
    Nadasdy T; Smith J; Laszik Z; Waner JL; Johnson LD; Silva FG
    Mod Pathol; 1994 Apr; 7(3):289-94. PubMed ID: 8058700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytomegalovirus infection and kidney graft survival.
    Spencer ES; Fjeldborg O; Andersen HK
    Scand J Urol Nephrol Suppl; 1981; 64():128-31. PubMed ID: 6293049
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vaccination against cytomegalovirus, the changeling demon.
    Plotkin SA
    Pediatr Infect Dis J; 1999 Apr; 18(4):313-25; quiz 326. PubMed ID: 10223683
    [No Abstract]   [Full Text] [Related]  

  • 53. Seronegative blood products prevent primary cytomegalovirus infection after bone marrow transplantation.
    Mackinnon S; Burnett AK; Crawford RJ; Cameron S; Leask BG; Sommerville RG
    J Clin Pathol; 1988 Sep; 41(9):948-50. PubMed ID: 2848062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients.
    Costa C; Astegiano S; Terlizzi ME; Sidoti F; Curtoni A; Solidoro P; Baldi S; Bergallo M; Cavallo R
    Transplant Proc; 2011 May; 43(4):1159-61. PubMed ID: 21620077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Humoral and cellular response after varicella vaccination in VZV IgG seronegative kidney transplant candidates.
    Kho MM; Zuijderwijk JM; van der Eijk AA; de Kuiper R; Boer-Verschragen MJ; Weimar W; van Besouw NM
    Vaccine; 2017 Jan; 35(1):71-76. PubMed ID: 27899225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytomegalovirus-specific CD8+ T cells do not develop in all renal transplant patients at risk of virus infection.
    Christmas SE; Halliday D; Lawton N; Wang H; Abdalla I; Masters J; Hassan RL; Hart IJ; Khan N; Smith J; Hammad A; Bakran A
    Transpl Immunol; 2009 Dec; 22(1-2):99-104. PubMed ID: 19635559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perspectives for the control of cytomegalovirus infections in bone marrow transplant recipients.
    Pollard RB; Merigan TC
    Transplant Proc; 1978 Mar; 10(1):241-5. PubMed ID: 205021
    [No Abstract]   [Full Text] [Related]  

  • 58. Should renal-transplant patients be screened for C.M.V.?
    Lancet; 1978 Oct; 2(8093):770-1. PubMed ID: 80691
    [No Abstract]   [Full Text] [Related]  

  • 59. Sepsis after renal transplantation: Clinical, immunological, and microbiological risk factors.
    Schachtner T; Stein M; Reinke P
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28296035
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dendritic cell vaccination in allogeneic stem cell recipients: induction of human cytomegalovirus (HCMV)-specific cytotoxic T lymphocyte responses even in patients receiving a transplant from an HCMV-seronegative donor.
    Grigoleit GU; Kapp M; Hebart H; Fick K; Beck R; Jahn G; Einsele H
    J Infect Dis; 2007 Sep; 196(5):699-704. PubMed ID: 17674311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.